Clinical Research in Cardiology

Article	Citations
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China	1327
NAFLD and cardiovascular diseases: a clinical review	271
Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity	228
Impaired cardiac function is associated with mortality in patients with acute COVID-19 infection	96
Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future	72
Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology	70
Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients	68
Impact of the COVID-19 pandemic on cardiovascular mortality and catherization activity during the lockdown in central Germany: an observational study	58
Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK)	57
Echocardiographic characteristics of patients with SARS-CoV-2 infection	55
COVID-19 among heart transplant recipients in Germany: a multicenter survey	55
Impact of COVID-19 outbreak on regional STEMI care in Germany	50
Temporal trends in the presentation of cardiovascular and cerebrovascular emergencies during the COVID-19 pandemic in Germany: an analysis of health insurance claims	50
Decline of emergency admissions for cardiovascular and cerebrovascular events after the outbreak of COVID-19	44
Impact of oral anticoagulation on clinical outcomes of COVID-19: a nationwide cohort study of hospitalized patients in Germany	43
Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation	40
Mobile health solutions for atrial fibrillation detection and management: a systematic review	39
Radiosurgery for ventricular tachycardia: preclinical and clinical evidence and study design for a German multi-center multi-platform feasibility trial (RAVENTA)	38
Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials	35
31 days of COVID-19—cardiac events during restriction of public life—a comparative study	33
The ACURATE neo2 valve system for transcatheter aortic valve implantation: 30-day and 1-year outcomes	32
Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study	29
The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk	29
Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination	29
Collateral damage of COVID-19-lockdown in Germany: decline of NSTE-ACS admissions	29

Pathomechanisms and therapeutic opportunities in radiation-induced heart disease: from bench to bedside	28
Cardiogenic shock: incidence, survival and mechanical circulatory support usage 2007–2017-insights from a national registry	28
Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-C	28
The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis	27
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study	27
Estimated plasma volume status in heart failure: clinical implications and future directions	27
Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report	27
Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge	26
Effect of frailty on treatment, hospitalisation and death in patients with chronic heart failure	25
Physical activity, sedentary behavior and risk of coronary artery disease, myocardial infarction and ischemic stroke: a two-sample Mendelian randomization study	25
Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?	25
Global longitudinal strain by feature tracking for optimized prediction of adverse remodeling after ST-elevation myocardial infarction	24
Concomitant tricuspid regurgitation severity and its secondary reduction determine long-term prognosis after transcatheter mitral valve edge-to-edge repair	24
Association between right-sided cardiac function and ultrasound-based pulmonary congestion on acutely decompensated heart failure: findings from a pooled analysis of four cohort studies	24
Atrial fibrillation ablation strategies and technologies: past, present, and future	24
The mystery of “missing” visits in an emergency cardiology department, in the era of COVID-19.; a time-series analysis in a tertiary Greek General Hospital	23
Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry	23
Energy intake during hospital stay predicts all-cause mortality after discharge independently of nutritional status in elderly heart failure patients	23
Effects of face masks on performance and cardiorespiratory response in well-trained athletes	23
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study	23
Colchicine in ischemic heart disease: the good, the bad and the ugly	22
Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial	22
Machine learning in the detection and management of atrial fibrillation	22
Comparisons of the risk of myopericarditis between COVID-19 patients and individuals receiving COVID-19 vaccines: a population-based study	21
Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis	21
Outcome of patients treated with extracorporeal life support in cardiogenic shock complicating acute myocardial infarction: 1-year result from the ECLS-Shock study	21
Temporal trends of TAVI treatment characteristics in high volume centers in Germany 2013–2020	20
Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditis	20
Left atrial appendage closure in patients with chronic kidney disease: results from the German multicentre LAARGE registry	20
Prognostic implications of pericardial and pleural effusion in patients with cardiac amyloidosis	20
Patients with acute myocarditis and preserved systolic left ventricular function: comparison of global and regional longitudinal strain imaging by echocardiography with quantification of late gadolini	19
Prognostic impact of plasma volume estimated from hemoglobin and hematocrit in heart failure with preserved ejection fraction	19
Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data	19
Iron deficiency is a common disorder in general population and independently predicts all-cause mortality: results from the Gutenberg Health Study	19
Prognostic value of NT-proBNP for myocardial recovery in peripartum cardiomyopathy (PPCM)	19
Acute myocardial infarction due to coronary stent thrombosis in a symptomatic COVID-19 patient	19
Transcatheter and surgical aortic valve replacement in patients with bicuspid aortic valve	18
Pulsed-field ablation-based pulmonary vein isolation: acute safety, efficacy and short-term follow-up in a multi-center real world scenario	18
Bacterial biofilms in infective endocarditis: an in vitro model to investigate emerging technologies of antimicrobial cardiovascular device coatings	18
PASCAL versus MitraClip-XTR edge-to-edge device for the treatment of tricuspid regurgitation: a propensity-matched analysis	18
Heyde syndrome: prevalence and outcomes in patients undergoing transcatheter aortic valve implantation	18
Clinical and cardiac magnetic resonance findings in post-COVID patients referred for suspected myocarditis	18
Long-term safety of paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease: the SPARTAN DCB study	18
Automatic positive airway pressure for obstructive sleep apnea in heart failure with reduced ejection fraction	18
Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity: the numbers do not add up	17
Timely and individualized heart failure management: need for implementation into the new guidelines	17
Incidence and outcomes of perioperative myocardial infarction/injury diagnosed by high-sensitivity cardiac troponin I	17
Analysis of length of stay after transfemoral transcatheter aortic valve replacement: results from the FRANCE TAVI registry	17
Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry	16
Safety and effectiveness of coronary intravascular lithotripsy in eccentric calcified coronary lesions: a patient-level pooled analysis from the Disrupt CAD I and CAD II Studies	16

Biomarkers as predictors of recurrence of atrial fibrillation post ablation: an updated and expanded systematic review and meta-analysis	16
Early onset of hyperuricemia is associated with increased cardiovascular disease and mortality risk	16
CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy	16
Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trial	16
Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation	15
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry	15
Outcomes of conduction system pacing compared to right ventricular pacing as a primary strategy for treating bradyarrhythmia: systematic review and meta-analysis	15
Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysis	15
COVID-19 vaccination and carditis in children and adolescents: a systematic review and meta-analysis	15
Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review	15
PASCAL mitral valve repair system versus MitraClip: comparison of transcatheter edge-to-edge strategies in complex primary mitral regurgitation	15
Spot urinary sodium in acute decompensation of advanced heart failure and dilutional hyponatremia: insights from DRAIN trial	15
Short- and long-term outcomes after heart transplantation in cardiac sarcoidosis and giant-cell myocarditis: a systematic review and meta-analysis	15
Machine learning-based risk prediction of intrahospital clinical outcomes in patients undergoing TAVI	14
Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndrome	14
Transcatheter aortic valve implantation in patients with a small aortic annulus: performance of supra-, intra- and infra-annular transcatheter heart valves	14
Ultrasound indices of congestion in patients with acute heart failure according to body mass index	14
Venting during venoarterial extracorporeal membrane oxygenation	14
Pacemaker lead-associated tricuspid regurgitation in patients with or without pre-existing right ventricular dilatation	13
No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity	13
Midregional pro atrial natriuretic peptide: a novel important biomarker for noise annoyance-induced cardiovascular morbidity and mortality?	13
Obstructive sleep apnoea but not central sleep apnoea is associated with left ventricular remodelling after acute myocardial infarction	13
Factors associated with in-hospital mortality and adverse outcomes during the vulnerable post-discharge phase after the first episode of acute heart failure: results of the NOVICA-2 study	13
Outcomes in patients with acute myocardial infarction and new atrial fibrillation: a nationwide analysis	13
Assessment of coronary artery disease during hospitalization for cancer treatment	13
Pulmonary artery sensor system pressure monitoring to improve heart failure outcomes (PASSPORT-HF): rationale and design of the PASSPORT-HF multicenter randomized clinical trial	13
Complications and mortality after catheter ablation of ventricular arrhythmias: risk in VT ablation (RIVA) score	13
Sex disparities and adverse cardiovascular and kidney outcomes in patients with chronic kidney disease: results from the KNOW-CKD	13
Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis	13
Device-related risk of atrial fibrillation after closure of patent foramen ovale: a systematic review and meta-analysis	12
Cardiac sympathetic denervation in patients with nonischemic cardiomyopathy and refractory ventricular arrhythmias: a single-center experience	12
Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis	12
Catheter ablation of short-coupled variant of torsade de pointes	12
Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients	12
Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry	12
Echocardiographic assessment of mitral regurgitation: discussion of practical and methodologic aspects of severity quantification to improve diagnostic conclusiveness	12
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry	12
Expert opinion paper on cardiac imaging after ischemic stroke	12
Reduction in cardiovascular emergency admissions in Monaco during the COVID-19 pandemic	12
Covariate adjusted reanalysis of the I-Preserve trial	11
Diagnostic value of the novel CMR parameter “myocardial transit-time” (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy	11
Aortic valve replacement in Germany in 2019	11
Reduction of permanent pacemaker implantation by using the cusp overlap technique in transcatheter aortic valve replacement: a meta-analysis	11
Global longitudinal strain improves risk assessment after ST-segment elevation myocardial infarction: a comparative prognostic evaluation of left ventricular functional parameters	11
Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia	11
Transcatheter or surgical aortic valve implantation in chronic dialysis patients: a German Aortic Valve Registry analysis	11
“Get with the Guidelines Heart Failure Risk Score” for mortality prediction in patients undergoing MitraClip	11
Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis	11
The diagnostic benefit of 16S rDNA PCR examination of infective endocarditis heart valves: a cohort study of 146 surgical cases confirmed by histopathology	11
Interplay of COVID-19 and cardiovascular diseases in Africa: an observational snapshot	11
Impact of real-time angiographic co-registered optical coherence tomography on percutaneous coronary intervention: the OPTICO-integration II trial	11
10-year follow-up of interventional electrophysiology: updated German survey during the COVID-19 pandemic	11
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure	10
Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry	10
Morbidity and mortality in adults with congenital heart defects in the third and fourth life decade	10
Combined renal and common hepatic artery denervation as a novel approach to reduce cardiometabolic risk: technical approach, feasibility and safety in a pre-clinical model	10
The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial	10
Guideline-directed medical therapy in real-world heart failure patients with low blood pressure and renal dysfunction	10
Disturbing effect of lockdown for COVID-19 on the incidence of infective endocarditis: a word of caution	10
Outcome of aortic stenosis according to invasive cardiac damage staging after transcatheter aortic valve replacement	10
Analysis of YouTube videos as a source of information for myocarditis during the COVID-19 pandemic	10
Cost-effectiveness of noninvasive telemedical interventional management in patients with heart failure: health economic analysis of the TIM-HF2 trial	10
Clinical outcomes and thrombus resolution in patients with solid left atrial appendage thrombi: results of a single-center real-world registry	10
Cardiovascular profiling in the diabetic continuum: results from the population-based Gutenberg Health Study	9
Instant rule-out of suspected non-ST-segment elevation myocardial infarction using high-sensitivity cardiac troponin T with Copeptin versus a single low high-sensitivity cardiac troponin T: findings f	9
Effects of the COVID-19 pandemic on acute coronary syndromes in Germany during the first wave: the COVID-19 collateral damage study	9
Recurrent infective endocarditis versus first-time infective endocarditis after heart valve surgery	9
Iron deficiency and short-term adverse events in patients with decompensated heart failure	9
The INFluence of Remote monitoring on Anxiety/depRession, quality of lifE, and Device acceptance in ICD patients: a prospective, randomized, controlled, single-center trial	9
Echocardiography-derived total atrial conduction time (PA-TDI duration): risk stratification and guidance in atrial fibrillation management	9
Efficacy and safety of intravenous iron repletion in patients with heart failure: a systematic review and meta-analysis	9
Multivessel versus culprit-only PCI in STEMI patients with multivessel disease: meta-analysis of randomized controlled trials	9
Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD)	9
COVID-19 sends STEMI to quarantine!?	9
Impact of chronic obstructive pulmonary disease on 10-year mortality after percutaneous coronary intervention and bypass surgery for complex coronary artery disease: insights from the SYNTAX Extended	9
One- and 3-year outcomes of percutaneous bifurcation left main revascularization with modern drug-eluting stents: a systematic review and meta-analysis	9
Prevention of coronary obstruction in patients at risk undergoing transcatheter aortic valve implantation: the Hamburg BASILICA experience	9
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction	9
Metabolomic profiling of patients with high gradient aortic stenosis undergoing transcatheter aortic valve replacement	9
TAVI in patients with low-flow low-gradient aortic stenosis–short-term and long-term outcomes	9

Functional and prognostic implications of cardiac magnetic resonance feature tracking-derived remote myocardial strain analyses in patients following acute myocardial infarction	9
Serum potassium dynamics during acute heart failure hospitalization	9
Early arrhythmia recurrence after catheter ablation for persistent atrial fibrillation: is it predictive for late recurrence?	8
Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial	8
Impact of cancer history on clinical outcome in patients undergoing transcatheter edge-to-edge mitral repair	8
Comorbidities complicating heart failure: changes over the last 15 years	8
Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities	8
Mid-term hemodynamic and functional results after transcatheter mitral valve leaflet repair with the new PASCAL device	8
Impact of effective regurgitant orifice area on outcome of secondary mitral regurgitation transcatheter repair	8
Predictors of high residual gradient after transcatheter aortic valve replacement in bicuspid aortic valve stenosis	8
Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction (“Jena auf Ziel”)	8
The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome	8
Short- and long-term outcome of patients with spontaneous echo contrast or thrombus in the left atrial appendage in the era of the direct acting anticoagulants	8
Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial	8
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction	8
Heart rate variability and atrial fibrillation in the general population: a longitudinal and Mendelian randomization study	8
Echocardiographic diagnosis of atrial cardiomyopathy allows outcome prediction following pulmonary vein isolation	8
Non-aortic cardiovascular disease in Marfan syndrome: a nationwide epidemiological study	8
New technologies for intensive prevention programs after myocardial infarction: rationale and design of the NET-IPP trial	8
Epicardial access for VT ablation: analysis of two different puncture techniques, incidence of adhesions and complication management	8
Therapeutic value of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) with cardiomyopathy based on cardiovascular magnetic resonance (CMR) imaging	8
Prognostic value of the chest X-ray in patients hospitalised for heart failure	8
Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice	8
Long-term outcome of perimembranous VSD closure using the Nit-Occlud® Lê VSD coil system	8
Outcomes of acute coronary syndromes in coronavirus disease 2019	8
Capacity changes in German certified chest pain units during COVID-19 outbreak response	8
Clinical outcomes of drug-coated balloon in coronary lesions: a real-world, all-comers study	7
Admission blood glucose level and outcome in patients requiring venoarterial extracorporeal membrane oxygenation	7
Non-invasive evaluation of retinal vascular remodeling and hypertrophy in humans: intricate effect of ageing, blood pressure and glycaemia	7
Propensity matched comparison of TAVI and SAVR in intermediate-risk patients with severe aortic stenosis and moderate-to-severe chronic kidney disease: a subgroup analysis from the German Aortic Valve	7
Safety and patient-reported outcomes in index ablation versus repeat ablation in atrial fibrillation: insights from the German Ablation Registry	7
Determinants of fibrotic atrial cardiomyopathy in atrial fibrillation. A multicenter observational study of the RETAC (reseau européen de traîtement d’arrhythmies cardiaques)-group	7
Complex vs. non-complex percutaneous coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials	7
Ten-year clinical outcomes of polymer-free versus durable polymer new-generation drug-eluting stent in patients with coronary artery disease with and without diabetes mellitus	7
Quantitative flow ratio (QFR) identifies functional relevance of non-culprit lesions in coronary angiographies of patients with acute myocardial infarction	7
Pregnancy-related acute myocardial infarction: a review of the recent literature	7
How long is long enough? Good neurologic outcome in out-of-hospital cardiac arrest survivors despite prolonged resuscitation: a retrospective cohort study	7
Prospective blinded evaluation of smartphone-based ECG for differentiation of supraventricular tachycardia from inappropriate sinus tachycardia	7
Immunothrombosis and new-onset atrial fibrillation in the general population: the Rotterdam Study	7
Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial	7
The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitors	7
Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction	7
The impact of epicardial adipose tissue in patients with acute myocardial infarction	7
Expert proposal to characterize cardiac diseases with normal or preserved left ventricular ejection fraction and symptoms of heart failure by comprehensive echocardiography	7
Thromboembolic complications in adult congenital heart disease: the knowns and the unknowns	7
Medical and cardio-vascular emergency department visits during the COVID-19 pandemic in 2020: is there a collateral damage? A retrospective routine data analysis	7
Early results of a real-world series with two transapical transcatheter mitral valve replacement devices	7
Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities	7
Impact of wearing a facial covering on aerobic exercise capacity in the COVID-19 era: is it more than a feeling?	7
Long-term follow-up of patients undergoing renal sympathetic denervation	7
Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry	7
Impact of pulse pressure on clinical outcome in extracorporeal cardiopulmonary resuscitation (eCPR) patients	7
Deferral of non-emergency cardiac procedures is associated with increased early emergency cardiovascular hospitalizations	7
Very early infective endocarditis after transcatheter aortic valve replacement	6
Establishing a cardiac training group for patients with heart failure: the “HIP-in-Würzburg” study	6
Clinical, procedural and long-term outcome of ischemic VT ablation in patients with previous anterior versus inferior myocardial infarction	6
Kidney injury as post-interventional complication of TAVI	6
Critical appraisal of the 2020 ESC guideline recommendations on diagnosis and risk assessment in patients with suspected non-ST-segment elevation acute coronary syndrome	6
Hemodynamics of self-expanding versus balloon-expandable transcatheter heart valves in relation to native aortic annulus anatomy	6
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation	6
Left atrial appendage closure in patients with a reduced left ventricular ejection fraction: results from the multicenter German LAARGE registry	6
Real-world anticoagulatory treatment after percutaneous mitral valve repair using MitraClip: a retrospective, observational study on 1300 patients	6
Body fluid regulation via chronic inhibition of sodium–glucose cotransporter-2 in patients with heart failure: a post hoc analysis of the CANDLE trial	6
Who is who in cardiovascular research? What a review of Nobel Prize nominations reveals about scientific trends	6
A SARS-Cov2-negative corona victim	6
Impact of frailty on periprocedural health care utilization in patients undergoing transcatheter edge-to-edge mitral valve repair	6
Rationale and design of the EPCHF trial: the early palliative care in heart failure trial (EPCHF)	6
Chronic cigarette smoking is associated with increased arterial stiffness in men and women: evidence from a large population-based cohort	6
Heart failure-related quality-of-life impairment after myocardial infarction	6
In-hospital outcomes of self-expanding and balloon-expandable transcatheter heart valves in Germany	6
Impact of ultra-marathon and marathon on biomarkers of myocyte necrosis and cardiac congestion: a prospective observational study	6
High interindividual variability in LDL-cholesterol reductions after inclisiran administration in a real-world multicenter setting in Germany	6
Changes in left atrial function in patients undergoing cardioversion for atrial fibrillation: relevance of left atrial strain in heart failure	6
Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial	6
Transcatheter-based aortic valve replacement vs. isolated surgical aortic valve replacement in 2020	6
Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINE	5
Exercise hemodynamics in heart failure patients with preserved and mid-range ejection fraction: key role of the right heart	5
Predictors for low TAVI-prosthesis position assessed by fusion imaging of pre- and post-procedural CT angiography	5
Implanted haemodynamic telemonitoring devices to guide management of heart failure: a review and meta-analysis of randomised trials	5
Relationship between non-invasively detected liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome undergoing PCI	5
Nighttime hemodynamic phenotype. A novel risk factor for cardiovascular disease, especially heart failure: the practitioner-based nationwide JAMP study	5
Genetically determined intelligence and coronary artery disease risk	5
Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials	5
Serum sodium and eplerenone use in patients with a myocardial infarction and left ventricular dysfunction or heart failure: insights from the EPHESUS trial	5
Prognosis of cardiogenic shock with and without acute myocardial infarction: results from a prospective, monocentric registry	5
Significance of myeloperoxidase plasma levels as a predictor for cardiac resynchronization therapy response	5
COVID-19 pandemic affects STEMI numbers and in-hospital mortality: results of a nationwide analysis in Germany	5
Ethnic comparison in takotsubo syndrome: novel insights from the International Takotsubo Registry	5
Diagnostic value of 18F-FDG PET/CT in infective endocarditis	5
Hypercholesterolemia diagnosis, treatment patterns and target achievement in patients with acute coronary syndromes in Germany	5
Pitfalls of the S-ICD therapy: experiences from a large tertiary centre	5
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI	5
Epidemiology of cardiac amyloidosis in Germany: a retrospective analysis from 2009 to 2018	5
Left ventricular function recovery after ST-elevation myocardial infarction: correlates and outcomes	5
Target and non-target vessel related events at 10 years post percutaneous coronary intervention	5